A detailed history of Spears Abacus Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 170,206 shares of JNJ stock, worth $24.6 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
170,206
Previous 170,464 0.15%
Holding current value
$24.6 Million
Previous $24.9 Million 10.71%
% of portfolio
0.58%
Previous 0.54%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $37,533 - $43,184
-258 Reduced 0.15%
170,206 $27.6 Million
Q2 2024

Aug 12, 2024

SELL
$144.38 - $157.78 $254,397 - $278,008
-1,762 Reduced 1.02%
170,464 $24.9 Million
Q1 2024

May 10, 2024

BUY
$155.22 - $162.74 $18.5 Million - $19.4 Million
118,982 Added 223.47%
172,226 $27.2 Million
Q3 2023

Nov 21, 2023

SELL
$155.75 - $174.48 $190,015 - $212,865
-1,220 Reduced 2.24%
53,244 $8.29 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $2,778 - $2,989
18 Added 0.03%
54,464 $9.01 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $93,802 - $111,941
621 Added 1.15%
54,446 $8.44 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $831,117 - $932,750
-5,188 Reduced 8.79%
53,825 $9.51 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $25,328 - $28,184
-157 Reduced 0.27%
59,013 $9.64 Million
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $13,959 - $15,438
83 Added 0.14%
59,170 $10.5 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $234,047 - $265,793
-1,480 Reduced 2.44%
59,087 $10.5 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $812,239 - $901,209
5,209 Added 9.41%
60,567 $10.4 Million
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $78,304 - $83,995
491 Added 0.89%
55,358 $9.12 Million
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $6,582 - $7,330
-43 Reduced 0.08%
54,867 $9.02 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $171,387 - $196,725
-1,250 Reduced 2.23%
54,910 $8.64 Million
Q3 2020

Nov 16, 2020

BUY
$140.38 - $153.83 $18,951 - $20,767
135 Added 0.24%
56,160 $8.36 Million
Q2 2020

Aug 12, 2020

BUY
$128.81 - $155.51 $69,042 - $83,353
536 Added 0.97%
56,025 $7.88 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $157,263 - $217,895
1,415 Added 2.62%
55,489 $7.28 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $63,622 - $73,073
499 Added 0.93%
54,074 $7.89 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $138,121 - $154,648
-1,088 Reduced 1.99%
53,575 $6.93 Million
Q2 2019

Aug 09, 2019

SELL
$131.15 - $144.24 $240,660 - $264,680
-1,835 Reduced 3.25%
54,663 $7.61 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $31,430 - $34,947
-250 Reduced 0.44%
56,498 $7.9 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $170,870 - $205,645
-1,391 Reduced 2.39%
56,748 $7.32 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $835 - $922
7 Added 0.01%
58,139 $7.06 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $314,626 - $372,572
-2,515 Reduced 4.15%
58,132 $7.45 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $1.21 Million - $1.33 Million
9,248 Added 17.99%
60,647 $8.47 Million
Q2 2017

Aug 11, 2017

BUY
N/A
51,399
51,399 $6.8 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Spears Abacus Advisors LLC Portfolio

Follow Spears Abacus Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.